Says gross margin expansion is a “high priority.” Says robust pipeline will sustain growth through 2025 and beyond. Expects to launch nutritional drink for GLP-1 users this year. Says will be “selective” with M&A as company’s strong pipeline should provide organic revenue growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ABT:
- Abbott (NYSE:ABT) Drops on Q4 Numbers
- Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
- Options Volatility and Implied Earnings Moves Today, January 24, 2024
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- Abbott Laboratories (ABT) Q4 Earnings Cheat Sheet
